title: Bridging study of S12024 in 53 in-patients with Alzheimer's disease.
authors.forename: H
authors.initials: H
authors.lastname: Allain
authors.forename: E
authors.initials: E
authors.lastname: Neuman
authors.forename: M
authors.initials: M
authors.lastname: Malbezin
authors.forename: V
authors.initials: V
authors.lastname: Salzman
authors.forename: D
authors.initials: D
authors.lastname: Guez
authors.forename: K
authors.initials: K
authors.lastname: Wesnes
authors.forename: J M
authors.initials: JM
authors.lastname: Gandon
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage* / Q000009:adverse effects; D011597:Psychomotor Performance / Q000187:drug effects; D011804:Quinolines / Q000008:administration & dosage* / Q000009:adverse effects; D011897:Random Allocation
chemical_list: D009025:Morpholines; D011804:Quinolines; C086272:S 12024